The conundrum of protection from AKI by adenosine in rodent clamp ischemia models

Kidney International

Volumn 84, Issue 1, 2013, Pages 16-19

  Venkatachalam, Manjeri A ^a   Weinberg, Joel M ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; CD39 ANTIGEN; ISOFLURANE; PENTOBARBITAL; SOMATOMEDIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE KIDNEY FAILURE; ANTIINFLAMMATORY ACTIVITY; CD4+ T LYMPHOCYTE; CELL PROTECTION; DENDRITIC CELL; DRUG EFFECT; DRUG EFFICACY; INFLAMMATION; INNATE IMMUNITY; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; NATURAL KILLER CELL; NATURAL KILLER T CELL; NO REFLOW PHENOMENON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84879661477     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.101     Document Type: Note

References (16)

1. Timsit MO, Garcia-Cardena G. Flow-dependent endothelial function and kidney dysfunction. Semin Nephrol 2012; 32: 185-191.
2. Laubach VE, French BA, Okusa MD. Targeting of adenosine receptors in ischemiareperfusion injury. Expert Opin Ther Targets 2011; 15: 103-118.
3. Li L, Okusa MD. Blocking the immune response in ischemic acute kidney i njury: the role of adenosine 2A agonists Nat Clin Pract Nephrol 2006; 2: 432-444.
4. Rabb H. The promise of immune cell therapy for acute kidney injury. J Clin Invest 2012; 122: 3852-3854.
5. Grenz A, Bauerle JD, Dalton JH et al. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012; 122: 693-710.
6. Kim M, Ham A, Kim JY et al. The volatile anesthetic isoflurane induces ecto-50- nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int 2013; 84: 90-103.
7. Hansen PB, Hashimoto S, Oppermann M et al. Vasoconstrictor and vasodilator effects of adenosine in the mouse kidney due to preferential activation of A1 or A2 adenosine receptors. J Pharmacol Exp Ther 2005; 315: 1150-1157.
8. Park SW, Kim JY, Ham A et al. A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2012; 303: F721-F732.
9. Bajwa A, Jo SK, Ye H et al. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemiareperfusion injury. J Am Soc Nephrol 2010; 21: 955-965.
10. Lee HT, Ota-Setlik A, Xu H et al. A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuriainduced renal failure. Am J Physiol Renal Physiol 2003; 284: F267-F273.
11. Li L, Huang L, Ye H et al. Dendritic cells tolerized with adenosine A(2)AR agonist attenuate acute kidney injury. J Clin Invest 2012; 122: 3931-3942.
12. Bauerle JD, Grenz A, Kim JH et al. Adenosine generation and signaling during acute kidney injury. J Am Soc Nephrol 2011; 22: 14-20.
13. Weinberg JM, Venkatachalam MA. Preserving postischemic reperfusion in the kidney: a role for extracellular adenosine. J Clin Invest 2012; 122: 493-496.
14. Riley AL, Alexander EA, Migdal S et al. The effect of ischemia on renal blood flow in the dog. Kidney Int 1975; 7: 27-34.
15. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278: F1-F12.
16. Parekh DJ, Weinberg JM, Ercole B et al. Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol 2013; 24: 506-517.